Skip to content

How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Healthy Sample)

Online RCT Comparing the Effects of Mindfulness, Sham Mindfulness and Book Listening Control on Coronavirus-related Catastrophizing in Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04602312
Enrollment
744
Registered
2020-10-26
Start date
2020-10-28
Completion date
2021-09-26
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catastrophizing Coronavirus (COVID-19)

Keywords

Coronavirus-related Catastrophizing

Brief summary

Both mindfulness meditation and expectancy effects are known to reduce anxiety, stress and catastrophizing, but it is unknown whether and how expectancy effects contribute to the overall effect of mindfulness meditation on these outcomes, especially during significant global events such as the coronavirus pandemic. This study includes four interrelated aims that will probe these effects and interactions.

Interventions

Participants will complete a single session of 20-minutes online guided audio-delivered training session of one of the four conditions.

Sponsors

University of Sydney
CollaboratorOTHER
University of California, San Diego
CollaboratorOTHER
The University of Queensland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

4 x (2) mixed design, with training (mindfulness vs specific sham mindfulness vs general sham mindfulness vs book listening control, between subjects) and time (pre-treatment vs post-treatment, within-subjects) as factors.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* At least 18 years of age * Able to read and understand English

Exclusion criteria

* Recurrent pain (two or more days in the last month) * Chronic pain (pain most days in the last three months) * Incomplete or invalid data (response time \< 32 minutes, failing attention checks) * Completing the 20-minute training module in \< 18 minutes or \> 90 minutes

Design outcomes

Primary

MeasureTime frameDescription
Coronavirus-related catastrophizing40 minutesassessed via a covid-19-related catastrophizing scale (CCS; 0=no catastrophizing, 52=highest catastrophizing, 30+=clinically significant catastrophizing)

Other

MeasureTime frameDescription
Mindful non-reactivity40 minutesassessed via the Five Facet Mindfulness Questionnaire Non-reacting subscale (FFMQ-NR; 1=lowest non-reactivity, 5=highest non-reactivity)
State Mindfulness40 minutesassessed via the State Mindfulness Survey (SMS; 1=lowest mindfulness, 21=highest mindfulness)
Mindful observing40 minutesassessed via the Five Facet Mindfulness Questionnaire Observing subscale (FFMQ-O; 1=lowest observing, 5=highest observing)
Expectancy40 minutesassessed via self-report questions (0=lowest expectancy, 10=highest expectancy)
Reappraisal40 minutesassessed via the Cognitive Emotion Regulation Questionnaire (CERQ-R; 4=lowest reappraisal, 20=highest reappraisal)
State Decentering40 minutesassessed via the Metacognitive Processes of Decentering - State (MpoD-s; 0=lowest decentering, 3=highest decentering)

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026